Statins and atrial fibrillation - mini - review on recent evidence
Bozena Sosnowska 1  
,  
Maciej Banach 1, 2  
 
 
More details
Hide details
1
Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Lodz, Poland
2
Polish Mother’s Memorial Hospital Research Institute (PMMHRI), Lodz, Poland
CORRESPONDING AUTHOR
Maciej Banach   

Department of Cardiology, Medical University of Lodz, Poland, Sterlinga 1/3, 91-425 Lodz, Poland
Publish date: 2017-01-17
 
Heart Beat 2016;1:43–46
KEYWORDS
TOPICS
ABSTRACT
Atrial fibrillation (AF) is the most common clinically significant cardiac arrhythmia, and it is associated with higher morbidity and mortality. However, treatment options for AF are still limited and often not effective. Studies indicated that statins might be associated with a decreased risk of incidence or recurrence of AF. The following review summarizes the key findings of the recent published studies.
eISSN:2543-6333